BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1786 related articles for article (PubMed ID: 18603558)

  • 1. Practice guidelines for the management of extranodal non-Hodgkin's lymphomas of adult non-immunodeficient patients. Part I: primary lung and mediastinal lymphomas. A project of the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.
    Zinzani PL; Martelli M; Poletti V; Vitolo U; Gobbi PG; Chisesi T; Barosi G; Ferreri AJ; Marchetti M; Pimpinelli N; Tura S; ; ;
    Haematologica; 2008 Sep; 93(9):1364-71. PubMed ID: 18603558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of nodal indolent (non marginal-zone) non-Hodgkin's lymphomas: practice guidelines from the Italian Society of Hematology, Italian Society of Experimental Hematology and Italian Group for Bone Marrow Transplantation.
    Barosi G; Carella A; Lazzarino M; Marchetti M; Martelli M; Rambaldi A; Tarella C; Vitolo U; Zinzani PL; Tura S
    Haematologica; 2005 Sep; 90(9):1236-57. PubMed ID: 16154848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of chronic lymphocytic leukemia: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.
    Brugiatelli M; Bandini G; Barosi G; Lauria F; Liso V; Marchetti M; Mauro FR; Meloni G; Zinzani PL; Tura S; ; ;
    Haematologica; 2006 Dec; 91(12):1662-73. PubMed ID: 17145603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of nodal diffuse large B-cell lymphomas: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.
    Barosi G; Carella A; Lazzarino M; Marchetti M; Martelli M; Rambaldi A; Tarella C; Vitolo U; Zinzani PL; Tura S; ; ;
    Haematologica; 2006 Jan; 91(1):96-103. PubMed ID: 16434377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
    Dawson LA; Saito NG; Ratanatharathorn V; Uberti JP; Adams PT; Ayash LJ; Reynolds CM; Silver SM; Schipper MJ; Lichter AS; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):208-18. PubMed ID: 15093918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence- and consensus-based practice guidelines for the therapy of primary myelodysplastic syndromes. A statement from the Italian Society of Hematology.
    Alessandrino EP; Amadori S; Barosi G; Cazzola M; Grossi A; Liberato LN; Locatelli F; Marchetti M; Morra E; Rebulla P; Visani G; Tura S;
    Haematologica; 2002 Dec; 87(12):1286-306. PubMed ID: 12495903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [High-grade non-Hodgkin lymphoma: diagnosis and therapy].
    Trümper L; Pfreundschuh M
    Ther Umsch; 1996 Feb; 53(2):133-9. PubMed ID: 8629263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B.
    Todeschini G; Secchi S; Morra E; Vitolo U; Orlandi E; Pasini F; Gallo E; Ambrosetti A; Tecchio C; Tarella C; Gabbas A; Gallamini A; Gargantini L; Pizzuti M; Fioritoni G; Gottin L; Rossi G; Lazzarino M; Menestrina F; Paulli M; Palestro M; Cabras MG; Di Vito F; Pizzolo G
    Br J Cancer; 2004 Jan; 90(2):372-6. PubMed ID: 14735179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical outcomes of different regimens for non-Hodgkin's lymphoma with bone marrow involvement: analysis of 148 cases].
    Li QC; Yuan XL; Wang YF; Zou DH; Zhao YZ; Qiu LG
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):254-7. PubMed ID: 18361837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patients.
    Zinzani PL; Martelli M; Bertini M; Gianni AM; Devizzi L; Federico M; Pangalis G; Michels J; Zucca E; Cantonetti M; Cortelazzo S; Wotherspoon A; Ferreri AJ; Zaja F; Lauria F; De Renzo A; Liberati MA; Falini B; Balzarotti M; Calderoni A; Zaccaria A; Gentilini P; Fattori PP; Pavone E; Angelopoulou MK; Alinari L; Brugiatelli M; Di Renzo N; Bonifazi F; Pileri SA; Cavalli F;
    Haematologica; 2002 Dec; 87(12):1258-64. PubMed ID: 12495899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent progress in the treatment of malignant lymphoma].
    Ogura M
    Gan To Kagaku Ryoho; 2001 Sep; 28(9):1213-35. PubMed ID: 11579632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Primary non-Hodgkin's high grade malignant lymphoma of the digestive system. A prospective study of the combination of surgery-chemotherapy-radiotherapy].
    Renou P; Colombat P; Fetissof F; Calais G; Metman EH; Combe M; Dugay J; Martin JF; Linassier C; Lamagnere JP
    Bull Cancer; 1990; 77(8):811-20. PubMed ID: 2207370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [5 years of dosage intensification and autologous bone marrow or peripheral stem cell transfusion in malignant lymphoma with a high risk of recurrence].
    Jost LM; Pichert G; Reichlin M; Müller E; Jacky E; Honegger HP; Gmür J; Stahel RA
    Schweiz Med Wochenschr; 1993 May; 123(18):932-40. PubMed ID: 8098878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of local control in patients with non-Hodgkin's lymphoma according to the WHO classification.
    Sakata K; Satoh M; Someya M; Nagakura H; Oouchi A; Nakata K; Kogawa K; Koito K; Hareyama M; Himi T
    Strahlenther Onkol; 2005 Jun; 181(6):385-91. PubMed ID: 15925981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Medicinal therapy of malignant lymphomas].
    Aul C; Schroeder M; Giagounidis A
    Radiologe; 2002 Dec; 42(12):943-53. PubMed ID: 12486548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy intensification with autologous transplantation in non-Hodgkin's lymphomas].
    Bosly A; Gisselbrecht C
    Bull Cancer; 2001 Sep; 88(9):877-87. PubMed ID: 11604361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Highly malignant non-Hodgkin's lymphomas].
    Fridrik MA
    Acta Med Austriaca; 1993; 20(3):70-7. PubMed ID: 8368049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffuse aggressive lymphomas: a curable subset of non-Hodgkin's lymphomas.
    Skarin AT
    Semin Oncol; 1986 Dec; 13(4 Suppl 5):10-25. PubMed ID: 2432666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical practice guidelines: non-Hodgkin's lymphomas.
    Fisher RI; Oken MM
    Cleve Clin J Med; 1995; 62 Suppl 1():SI6-42, quiz SI43-5. PubMed ID: 7641398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of aggressive non-Hodgkin's lymphomas.
    Tsartsidze E; Betaneli M; Sharikadze N; Shavidze N; Seskuria N
    Georgian Med News; 2007 Apr; (145):30-3. PubMed ID: 17525494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 90.